Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 16
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Insights into the causal role of diesel exhaust particles in ventricular arrhythmogenesis, protective effects of antioxidant cerium oxide nanoparticles

  • Ganse, Freddy G
  • Ernst, Lena M.|||0000-0002-5713-7513
  • Rodríguez Antona, Cristina|||0000-0001-8750-7338
  • Ruiz Meana, Marisol|||0000-0002-4067-4638
  • Inserte, Javier|||0000-0003-2283-3591
  • Martínez-González, José|||0000-0002-3894-7166
  • Briones, Ana|||0000-0001-8218-5579
  • Consegal, Marta|||0000-0002-9201-9117
  • Miró-Casas, Elisabet|||0000-0002-2058-5961
  • Yáñez-Bisbe, Laia|||0000-0001-9084-7296
  • Pomposo, Aitor
  • Prades, Marta
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
  • Puntes, Víctor|||0000-0001-8996-9499
  • Benito Villabriga, Begoña|||0000-0002-8668-1251
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
Epidemiological studies suggest an association between air pollution and ventricular arrhythmias, with reactive oxygen species (ROS) playing a crucial role. However, the causal relationship and long-term effects remain uncertain, and the effectiveness of interventions aimed at reducing ROS requires further investigation. Here we aimed to evaluate the effects of a 3-weeks exposure to diesel exhaust particles (DEPs) on ventricular arrhythmogenesis, explore the underlying mechanisms, and assess the potential of cerium oxide nanoparticles (CeONP) as a ROS-detoxifying intervention. Sprague-Dawley rats underwent intratracheal instillation of saline without or with DEPs (7.5 g/Kg for 1-3 weeks). Ventricular arrhythmia inducibility was then assessed in isolated hearts using a protocol of programmed electrical stimulation. Cardiac hypertrophy, collagen content, inflammation and oxidative stress were analyzed using histology, Western blot, RT-qPCR, and measurement of malondialdehyde content. The potential protective effects of CeONP (0.5 mg/Kg/week, i.p.) were also tested. DEP exposure for 3 weeks increased the incidence and duration of sustained ventricular tachyarrhythmias (VTs), a finding that correlated with a moderate increase in interstitial collagen (from 3.11 ± 0.12% in controls to 4.80 ± 0.21% in DEP-exposed rats, p. < 0.001), and an early upregulation in the expression of collagen and other fibrotic and inflammatory markers. These effects associated with prolonged QRS complex and enhanced malondialdehyde content (356.7 ± 21.2 vs. 455.3 ± 17.2 μmol/g tissue, p = 0.0066) after 3 weeks. CeO2NP treatment reduced oxidative stress and myocardial fibrosis, reversed electrocardiographic changes and attenuated DEP-induced pro-arrhythmic effects. Conclusions: DEP exposure increases the incidence and duration of sustained VTs, collagen deposition and oxidative stress in rats. Treatment with CeO2NP attenuate these effects, arising as a potential novel strategy to mitigate the deleterious effects of air pollution.
Repisalud
Publicación Artículo científico (JournalArticle)

Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes

  • Cedena, M Teresa
  • Rapado, Inmaculada
  • Santos-Lozano, Alejandro
  • Ayala, Rosa
  • Onecha, Esther
  • Abaigar, María
  • Such, Esperanza
  • Ramos, Fernando
  • Cervera, José
  • Díez-Campelo, María
  • Sanz, Guillermo
  • Rivas, Jesús Hernández
  • Lucía, Alejandro
  • Martinez-Lopez, Joaquin
We evaluated the association of mutations in 34 candidate genes and response to azacitidine in 84 patients with myelodysplastic syndrome (MDS), with 217 somatic mutations identified by next-generation sequencing. Most patients (93%) had ≥1 mutation (mean=2.6/patient). The overall response rate to azacitidine was 42%. No clinical characteristic was associated with response to azacitidine. However, total number of mutations/patient was negatively associated with overall drug response (odds ratio [OR]: 0.56, 95% confidence interval [CI]: 0.33-0.94; p=0.028), and a positive association was found for having ≥1 mutation in a DNA methylation-related gene: TET2, DNMT3A, IDH1 and/or IDH2 (OR: 4.76, 95%CI: 1.31-17.27; p=0.017). Mutations in TP53 (hazard ratio [HR]: 3.88; 95%CI: 1.94-7.75) and EZH2 (HR: 2.50; 95%CI: 1.23-5.09) were associated with shorter overall survival. Meta-analysis of 6 studies plus present data (n=815 patients) allowed assessment of the association of drug response with mutations in 9 candidate genes: ASXL1, CBL, EZH2, SF3B1, SRSF2, TET2, DNMT3A, IDH1/2 and TP53. TET2 mutations predicted a more favorable drug response compared with 'wild-type' peers (pooled OR: 1.67, 95%CI: 1.14-2.44; p=0.01). In conclusion, mutations in the DNA methylation pathway, especially TET2 mutations, and low number of total mutations are associated with a better response to azacitidine.
Repisalud
Publicación Artículo científico (JournalArticle)

Efficacy of the Otago-Exercise-Programme to reduce falls in community-dwelling adults aged 65-80 when delivered as group or individual training: Non-inferiority-clinical-trial

  • Albornos-Muñoz, Laura
  • Blanco-Blanco, Joan
  • Cidoncha-Moreno, María Ángeles
  • Abad-Corpa, Eva
  • Rivera-Álvarez, Araceli
  • López-Pisa, Rosa María
  • Caperos, José-Manuel
  • Otago Project Working Group Consortium
  • Moreno-Casbas, Teresa
  • Rich-Ruiz, Manuel
  • Rodriguez Baz
Background: The Otago Exercise Programme is an effective intervention for falls prevention. However, there is limited evidence in relation to studies that compare efficacy for falls prevention when delivered Otago Exercise Programme in a group or individual format in a primary care context. Objective: To compare the Otago Exercise Programme delivered as a group vs. individual format for community dwelling older adults, over a one year period. The hypothesis was that neither format would be inferior to the other. Methods: DESIGN: A four-year multicentre, randomized, non-inferiority clinical trial, with two arms- Otago Exercise Programme group training and individual Otago exercise training. Setting(s): 21 primary healthcare centers. Participants: A sample size of 728 participants was established. Participants were aged between 65 and 80 years; living in the community; able to walk independently; and agreed to take part in the study and provided signed informed consent. Intervention: The Otago Exercise Programme was delivered mainly by nurses in primary care, with five face to face sessions, and a reinforcement 6 months later. Participants were encouraged to exercise at home between face to face sessions. Data collection: at baseline and after 6 and 12 months from October 2017 to 2020. Primary outcome: people who reported at least one fall. Secondary outcomes: number of falls, cause of falls, consequences and assistance, adherence and satisfaction. Group allocation was blinded to the researchers involved in analysis. Reporting: Consolidated Standards of Reporting Trials recommendations for the Statement for Randomized Trials of Nonpharmacologic Treatments. Results: Eight hundred twenty-seven participants were randomized (226 were allocated in group training and 272 in individual training). The analysis of the proportion of people who reported at least one fall and number of falls showed no differences between individual and group training. Assessment of the equivalence between the interventions at 12 months showed that the confidence interval for the difference of people who reported at least one fall was found to be within the equivalence limit of 10% considered. However, in those participants with a previous history of falls, group format showed potentially greater benefit. The participants in individual training presented higher scores on the Exercise Adherence Rating Scale test. No differences were found in satisfaction between the groups. Conclusions: The group Otago Exercise Programme is equivalent to individually delivered Otago Exercise Programme in terms of prevention of falls over a 12-month follow up. Adherence was higher in individual training. Implications: Healthcare professionals could offer either Otago Exercise Programme format dependent on patient preference and be confident that that standardized intervention provides patient benefit. Trial registration: ClinicalTrials.gov (NCT03320668). Data registration 31/10/2017.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Cost-effectiveness of an exercise programme that provided group or individual training to reduce the fall risk in healthy community-dwelling people aged 65-80: a secondary data analysis

  • Aranda Reneo, Isaac
  • Albornos Muñoz, Laura
  • Rich Ruiz, Manuel
  • Cidoncha Moreno, María Ángeles
  • Pastor López, Ángeles
  • Moreno Casbas, María Teresa
  • Otago Project Working Group
  • Bays Moneo, Ana Beatriz
Ana Beatriz Bays Moneo pertenece al Otago Project Working Group, Research has demonstrated that some exercise programs are effective for reducing fall rates in community-dwelling older people; however, the literature is limited in providing clear recommendations of individual or group training as a result of economic evaluation. The objective of this study was to assess the cost-effectiveness of the Otago Exercise Program (OEP) for reducing the fall risk in healthy, non-institutionalized older people. An economic evaluation of a multicenter, blinded, randomized, non-inferiority clinical trial was performed on 498 patients aged over 65 in primary care. Participants were randomly allocated to the treatment or control arms, and group or individual training. The program was delivered in primary healthcare settings and comprised five initial sessions, ongoing encouragement and support to exercise at home, and a reinforcement session after six months. Our hypothesis was that the patients who received the intervention would achieve better health outcomes and therefore need lower healthcare resources during the follow-up, thus, lower healthcare costs. The primary outcome was the incremental cost-effectiveness ratio, which used the timed up and go test results as an effective measure for preventing falls. The secondary outcomes included differently validated tools that assessed the fall risk. The cost per patient was USD 51.28 lower for the group than the individual sessions in the control group, and the fall risk was 10% lower when exercises had a group delivery. The OEP program delivered in a group manner was superior to the individual method. We observed slight differences in the incremental cost estimations when using different tools to assess the risk of fall, but all of them indicated the dominance of the intervention group. The OEP group sessions were more cost-effective than the individual sessions, and the fall risk was 10% lower., This work was supported by Spanish National Fund for Health Research (ISCIII-Subdirección General de Evaluación y Fomento de la Investigación), grant numbers PI16CIII/00031 coordinator, PI16/01520, PI16/00821, PI16/01316, PI16/01649, PI16/01042, PI16/01159 and PI16/01312, and Regional Fund for Health Research (País Vasco & Murcia), grant numbers 2016111005 & FFIS17/AP/02/04.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

The relation between functional performance, falls and previous falls among participants in the Otago programme: a secondary data analysis

  • Company Sancho, María Consuelo
  • Alonso Poncelas, Emma
  • Rich Ruiz, Manuel
  • Cidoncha Moreno, María Ángeles
  • Gonzalez Pisano, Ana
  • Abad Corpa, Eva
  • Otago Project Working Group
  • Bays Moneo, Ana Beatriz
Ana Beatriz Bays Moneo pertenece al Otago Project Working Group, Fall prevention is a key priority in healthcare policies. Multicomponent exercises reduce the risk of falls. The purpose of this study is to describe the relationship between functional performance and falls after following the Otago multicomponent exercise programme and previous falls. A prospective multi-centre intervention study was performed on 498 patients aged over 65 in primary care, with or without a history of previous falls. Sociodemographic, anthropometric and functionality data were collected. The primary outcome was the occurrence of falls; functional performance was measured using the Tinetti, Short Physical Performance Battery and Timed Up and Go tests. Among the patients, 29.7% referred to previous falls. There was a statistically significant (p < 0.001) increase in falls at 6 months (10.1%) and at 12 months (7.6%) among participants with previous falls in the baseline assessment compared to those without. In addition, the existence of previous falls could be considered a risk factor at 6 and 12 months (OR =2.37, p = 0.002, and OR = 1.76, p = 0.046, respectively). With regard to balance and gait, differences between the groups were observed at 6 months in the Tinetti score (p < 0.001) and in the baseline assessment Timed Up and Go score (p < 0.044). Multicomponent exercises improve the fall rate, balance and gait in older people, although this improvement is less in people with previous falls. Earlier intervention and tailoring of exercises in patients with previous falls could help improve outcomes., The Project coordinated with file codes PI16/01520, PI16/00821, PI16/01316, PI16/01649, PI16/01042, PI16/01159 and PI16/01312 was funded by the Carlos III Health Institute through the Strategic Action in Health 2016 and co-funded by the European Regional Development Fund "A way to make Europe"; PI16CIII/00031 was funded by the Carlos III Health Institute through the 2016 Intramural Strategic Action in Health; 2016111005 was funded by the Government of the Basque Country Department of Health through the 2016 subsidies for research projects; FFIS17/AP/02/was funded by the Autonomous Community of the Region of Murcia through the Region of Murcia Foundation for Health Training and Research.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Efficacy of the Otago-Exercise-Programme to reduce falls in community-dwelling adults aged 65-80 when delivered as group or individual training: non-inferiority-clinical-trial

  • Albornos Muñoz, Laura
  • Blanco Blanco, Joan
  • Cidoncha Moreno, María Ángeles
  • Abad Corpa, Eva
  • Rivera-Álvarez, Araceli
  • López-Pisa, Rosa María
  • Caperos, José Manuel
  • Rodríguez Baz, María Pilar
  • Bays Moneo, Ana Beatriz
  • Pruneda, Laura
  • Skelton, Dawn A.
  • Todd, Chris
  • Townley, Rebecca
  • Pancorbo-Hidalgo, Pedro Luis
  • Caño-Blasco, Óscar
  • Solé-Agustí, María Cristina
  • Rich Ruiz, Manuel
  • Gonzalez Pisano, Ana
  • Miralles-Xamena, Jerónima
  • Company Sancho, María Consuelo
  • Moreno Casbas, María Teresa
Background The Otago Exercise Programme is an effective intervention for falls prevention. However, there is limited evidence in relation to studies that compare efficacy for falls prevention when delivered Otago Exercise Programme in a group or individual format in a primary care context. Objective To compare the Otago Exercise Programme delivered as a group vs. individual format for community dwelling older adults, over a one year period. The hypothesis was that neither format would be inferior to the other. Methods Design: A four-year multicentre, randomized, non-inferiority clinical trial, with two arms— Otago Exercise Programme group training and individual Otago exercise training. Setting(s): 21 primary healthcare centers. Partici‑ pants: A sample size of 728 participants was established. Participants were aged between 65 and 80 years; living in the community; able to walk independently; and agreed to take part in the study and provided signed informed consent. Intervention: The Otago Exercise Programme was delivered mainly by nurses in primary care, with five face to face sessions, and a reinforcement 6 months later. Participants were encouraged to exercise at home between face to face sessions. Data collection: at baseline and after 6 and 12 months from October 2017 to 2020. Primary outcome: people who reported at least one fall. Secondary outcomes: number of falls, cause of falls, consequences and assis‑ tance, adherence and satisfaction. Group allocation was blinded to the researchers involved in analysis. Reporting: Consolidated Standards of Reporting Trials recommendations for the Statement for Randomized Trials of Nonpharma‑ cologic Treatments. Results Eight hundred twenty-seven participants were randomized (226 were allocated in group training and 272 in individual training). The analysis of the proportion of people who reported at least one fall and number of falls showed no differences between individual and group training. Assessment of the equivalence between the interven‑ tions at 12 months showed that the confidence interval for the difference of people who reported at least one fall was found to be within the equivalence limit of 10% considered. However, in those participants with a previous his‑ tory of falls, group format showed potentially greater benefit. The participants in individual training presented higher scores on the Exercise Adherence Rating Scale test. No differences were found in satisfaction between the groups. Conclusions The group Otago Exercise Programme is equivalent to individually delivered Otago Exercise Programme in terms of prevention of falls over a 12-month follow up. Adherence was higher in individual training. Implications: Healthcare professionals could offer either Otago Exercise Programme format dependent on patient preference and be confident that that standardized intervention provides patient benefit., This study was funded by the Spanish National Fund for Health Research (grant numbers PI16CIII/00031 - coordinator, PI16/01520, PI16/00821, PI16/01316, PI16/01649, PI16/01042, PI16/01159 and PI16/01312) and the Regional Fund for Health Research (País Vasco & Murcia) (grant numbers 2016111005 & FFIS17/AP/02/04).
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Prevalence of falls in noninstitutionalized people aged 65-80 and associations with sex and functional tests: a multicenter observational study

  • Blanco Blanco, Joan
  • Albornos Muñoz, Laura
  • Costa Menen, María Àngels
  • García Martínez, Ester
  • Rubinat Arnaldo, Esther
  • Martínez Soldevila, Jordi
  • Moreno Casbas, María Teresa
  • Bays Moneo, Ana Beatriz
  • Gea Sánchez, Montserrat
  • Otago Project Working Group
Falls have a considerable impact on the functional prognosis of older adults. The main focus of this multicenter, retrospective, observational study was to xamine the prevalence of falls in Spanish people aged 65-80 years still living at home. The secondary aims included examining the overall sociodemographic and clinical variables associated with a history of falls and then stratifying these findings by sex. We also aimed to determine the differences between sexes with regard to the history and consequences of falls and to evaluate associations between fall history and functional performance tests. The 747 older adults had all participated in the otago exercise program, which is a progressive home program of strength, balance, and endurance exercises. They were recruited by nurses in 21 primary care centers in 10 Spanish provinces between September 2017 to December 2018. The participants' mean age was 72.2 (SD: 4.3) years, and 67% were women. We recorded sociodemographic and clinical variables, functional performance test results, and any falls and/or injuries in the last 12 months. We found that 32% had fallen, 36% of those had fallen more than once, and 48% had sustained injuries when they fell. The bivariate analysis showed that women had more than twice the odds of falling than men and that living alone and being obese or overweight increased the odds of a fall, although living alone was not associated with falls in the multivariable analysis. Our results could guide the development of risk-specific fall prevention programs to prevent disabilities in older people., Comunidad Autónoma de la Región de Murcia, Grant/Award Numbers: CARM, FFIS17/AP/02/ 04; European Regional Development Fund, Grant/Award Number: A way to make Europe; Basque Country, Grant/Award Number: 2016111005; Instituto de Salud Carlos III, Grant/Award Numbers: PI16/00821, PI16/01042, PI16/01159, PI16/01312, PI16/01316, PI16/01520, PI16/01649, PI16CIII/00031
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Novel pharmacological approaches in abdominal aortic aneurysm

  • Puertas-Umbert, Lídia
  • Almendra-Pegueros, Rafael
  • Jiménez-Altayó, Francesc
  • Sirvent, Marc
  • Galán, María
  • Martínez-González, José
  • Rodríguez-Sinovas, Cristina
Abdominal aortic aneurysm (AAA) is a severe vascular disease and a major public health issue with an unmet medical need for therapy. This disease is featured by a progressive dilation of the abdominal aorta, boosted by atherosclerosis, ageing, and smoking as major risk factors. Aneurysm growth increases the risk of aortic rupture, a life-threatening emergency with high mortality rates. Despite the increasing progress in our knowledge about the etiopathology of AAA, an effective pharmacological treatment against this disorder remains elusive and surgical repair is still the unique available therapeutic approach for high-risk patients. Meanwhile, there is no medical alternative for patients with small aneurysms but close surveillance. Clinical trials assessing the efficacy of antihypertensive agents, statins, doxycycline, or anti-platelet drugs, among others, failed to demonstrate a clear benefit limiting AAA growth, while data from ongoing clinical trials addressing the benefit of metformin on aneurysm progression are eagerly awaited. Recent preclinical studies have postulated new therapeutic targets and pharmacological strategies paving the way for the implementation of future clinical studies exploring these novel therapeutic strategies. This review summarises some of the most relevant clinical and preclinical studies in search of new therapeutic approaches for AAA., This research was funded by the Spanish Ministerio de Ciencia e Innovación (PID2021-122509OB-I00) [grant number MCIN/ AEI/10.13039/501100011033]; “ERDF A way of making Europe”; Instituto de Salud Carlos III (ISCIII) [grants numbers PI21/01048 and PI20/01649]; Fundación Española de Arteriosclerosis-Sociedad Española de Arteriosclerosis (Beca de Investigación Básica 2020); and Fondo Europeo de Desarrollo Regional (FEDER), a way to make Europe. L.P-U. and R.A.-P are supported by a PFIS fellowship (ISCIII)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Insights into the causal role of diesel exhaust particles in ventricular arrhythmogenesis: protective effects of antioxidant cerium oxide nanoparticles

  • Ganse, Freddy G.
  • Ernst, Lena M.
  • Rodríguez-Sinovas, Cristina
  • Ruíz-Meana, Marisol
  • Inserte, Javier
  • Martínez-González, José
  • Briones, Ana M.
  • García-Redondo, Ana Belén
  • Consegal, Marta
  • Miró-Casas, Elisabet
  • Yáñez-Bisbe, Laia
  • Pomposo, Aitor
  • Prades-Martínez, Marta
  • Ferreira-González, Ignacio
  • Puntes, Víctor F.
  • Benito, Begoña
  • Rodríguez-Sinovas, Antonio
[Background] Epidemiological studies suggest an association between air pollution and ventricular arrhythmias, with reactive oxygen species (ROS) playing a crucial role. However, the causal relationship and long-term effects remain uncertain, and the effectiveness of interventions aimed at reducing ROS requires further investigation. Here we aimed to evaluate the effects of a 3-weeks exposure to diesel exhaust particles (DEPs) on ventricular arrhythmogenesis, explore the underlying mechanisms, and assess the potential of cerium oxide nanoparticles (CeO2NP) as a ROS-detoxifying intervention., [Results] Sprague–Dawley rats underwent intratracheal instillation of saline without or with DEPs (7.5 g/Kg for 1–3 weeks). Ventricular arrhythmia inducibility was then assessed in isolated hearts using a protocol of programmed electrical stimulation. Cardiac hypertrophy, collagen content, inflammation and oxidative stress were analyzed using histology, Western blot, RT-qPCR, and measurement of malondialdehyde content. The potential protective effects of CeO2NP (0.5 mg/Kg/week, i.p.) were also tested. DEP exposure for 3 weeks increased the incidence and duration of sustained ventricular tachyarrhythmias (VTs), a finding that correlated with a moderate increase in interstitial collagen (from 3.11 ± 0.12% in controls to 4.80 ± 0.21% in DEP-exposed rats, p < 0.001), and an early upregulation in the expression of collagen and other fibrotic and inflammatory markers. These effects associated with prolonged QRS complex and enhanced malondialdehyde content (356.7 ± 21.2 vs. 455.3 ± 17.2 μmol/g tissue, p = 0.0066) after 3 weeks. CeO2NP treatment reduced oxidative stress and myocardial fibrosis, reversed electrocardiographic changes and attenuated DEP-induced pro-arrhythmic effects., [Conclusions] DEP exposure increases the incidence and duration of sustained VTs, collagen deposition and oxidative stress in rats. Treatment with CeO2NP attenuate these effects, arising as a potential novel strategy to mitigate the deleterious effects of air pollution., This work was supported by Instituto de Salud Carlos III (grants PI20/01649 and CIBERCV) and Ministerio de Ciencia e Innovación (FORTALECE-FORT23/0034), co-funded by the European Union (European Regional Development Fund, ERDF-FEDER, a way to build Europe), and Generalitat de Catalunya (PERIS STL028/23/00195 and AGAUR-2021SGR758). Antonio Rodríguez-Sinovas has a consolidated Miguel Servet contract., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

NR4A3: A Key Nuclear Receptor in Vascular Biology, Cardiovascular Remodeling, and Beyond

  • Rodríguez Sinovas, Antonio
  • Corrales Insa, Irene
  • Alonso Nieto, Judith
  • Ballester-Servera, Carme
  • Cañes Esteve, Laia
  • Rodriguez, Cristina
  • Martínez-González, José
Aneurisma aórtico abdominal; Aterosclerosis; Remodelación cardiovascular, Aneurisma aòrtic abdominal; Aterosclerosi; Remodelació cardiovascular, Abdominal aortic aneurysm; Atherosclerosis; Cardiovascular remodeling, The mechanisms committed in the activation and response of vascular and inflammatory immune cells play a major role in tissue remodeling in cardiovascular diseases (CVDs) such as atherosclerosis, pulmonary arterial hypertension, and abdominal aortic aneurysm. Cardiovascular remodeling entails interrelated cellular processes (proliferation, survival/apoptosis, inflammation, extracellular matrix (ECM) synthesis/degradation, redox homeostasis, etc.) coordinately regulated by a reduced number of transcription factors. Nuclear receptors of the subfamily 4 group A (NR4A) have recently emerged as key master genes in multiple cellular processes and vital functions of different organs, and have been involved in a variety of high-incidence human pathologies including atherosclerosis and other CVDs. This paper reviews the major findings involving NR4A3 (Neuron-derived Orphan Receptor 1, NOR-1) in the cardiovascular remodeling operating in these diseases., This research was funded by the Spanish Ministerio de Ciencia e Innovación (RTI2018-094727-B-100), Instituto de Salud Carlos III (ISCIII; PI18/0919 and PI20/01649), the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR; 2017-SGR-00333). The study was cofounded by Fondo Europeo de Desarrollo Regional (FEDER), a way to make Europe. C.B.-S. is supported by a FPU fellowship (Ministerio de Ciencia, Innovación y Universidades).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Activation of Wnt/β-catenin signaling in abdominal aortic aneurysm: A potential therapeutic opportunity?

  • Puertas-Umbert, Lidia
  • álvarez, saray
  • Ballester-Servera, Carme
  • Alonso Nieto, Judith
  • Aguiló, Silvia
  • Orriols, Mar
  • Rodriguez-Sinovas, Antonio
Abdominal aortic aneurysm, Aneurisma aórtico abdominal, Aneurisma aòrtic abdominal, This work was supported by Instituto de Salud Carlos III (ISCIII) (No. PI21/01048, PI20/01649), the European Regional Development Fund (ERDF-FEDER, a way to build Europe), Ministerio de Ciencia e Innovación (No. RTI2018-094727-B-100), AGAUR (No. 2017-SGR-00333, 2017-SGR-1807) and Consejo Superior de Investigaciones Científicas (No. 2021AEP073). L. P. is supported by a PFIS contract (ISCIII), C.B–S by a FPU fellowship and A.R.-S. and M.G. were funded by the Miguel Servet Program.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Nr4a3, A key nuclear receptor in vascular biology, cardiovascular remodeling and beyond

  • Martínez-González, José|||0000-0002-3894-7166
  • Cañes Esteve, Laia|||0000-0002-9579-1321
  • Alonso Nieto, Judith|||0000-0003-0537-0417
  • Ballester-Servera, Carme|||0000-0001-7858-3064
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • Corrales Insa, Irene|||0000-0002-0647-0340
  • Rodríguez, Cristina|||0000-0002-6472-5647
The mechanisms committed in the activation and response of vascular and inflammatory immune cells play a major role in tissue remodeling in cardiovascular diseases (CVDs) such as atherosclerosis, pulmonary arterial hypertension, and abdominal aortic aneurysm. Cardiovascular remodeling entails interrelated cellular processes (proliferation, survival/apoptosis, inflammation, extracellular matrix (ECM) synthesis/degradation, redox homeostasis, etc.) coordinately regulated by a reduced number of transcription factors. Nuclear receptors of the subfamily 4 group A (NR4A) have recently emerged as key master genes in multiple cellular processes and vital functions of different organs, and have been involved in a variety of high-incidence human pathologies including atherosclerosis and other CVDs. This paper reviews the major findings involving NR4A3 (Neuron-derived Orphan Receptor 1, NOR-1) in the cardiovascular remodeling operating in these diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Novel pharmacological approaches in abdominal aortic aneurysm

  • Puertas Umbert, Lídia|||0000-0002-2739-6522
  • Almendra-Pegueros, Rafael|||0000-0002-4411-4515
  • Jiménez Altayó, Francesc|||0000-0002-9034-2041
  • Sirvent, Marc|||0000-0001-5912-8760
  • Galán, María|||0000-0002-4758-8388
  • Martínez-González, José|||0000-0002-3894-7166
  • Rodríguez, Cristina|||0000-0002-6472-5647
Abdominal aortic aneurysm (AAA) is a severe vascular disease and a major public health issue with an unmet medical need for therapy. This disease is featured by a progressive dilation of the abdominal aorta, boosted by atherosclerosis, ageing, and smoking as major risk factors. Aneurysm growth increases the risk of aortic rupture, a life-threatening emergency with high mortality rates. Despite the increasing progress in our knowledge about the etiopathology of AAA, an effective pharmacological treatment against this disorder remains elusive and surgical repair is still the unique available therapeutic approach for high-risk patients. Meanwhile, there is no medical alternative for patients with small aneurysms but close surveillance. Clinical trials assessing the efficacy of antihypertensive agents, statins, doxycycline, or anti-platelet drugs, among others, failed to demonstrate a clear benefit limiting AAA growth, while data from ongoing clinical trials addressing the benefit of metformin on aneurysm progression are eagerly awaited. Recent preclinical studies have postulated new therapeutic targets and pharmacological strategies paving the way for the implementation of future clinical studies exploring these novel therapeutic strategies. This review summarises some of the most relevant clinical and preclinical studies in search of new therapeutic approaches for AAA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Activation of Wnt/β-catenin signaling in abdominal aortic aneurysm, A potential therapeutic opportunity?

  • Puertas Umbert, Lídia|||0000-0002-2739-6522
  • Varona, Saray|||0000-0002-7375-313X
  • Ballester-Servera, Carme|||0000-0001-7858-3064
  • Alonso Nieto, Judith|||0000-0003-0537-0417
  • Aguiló, Silvia|||0000-0003-0672-8388
  • Orriols, Mar
  • Martínez-Martínez, Ernesto
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • Martínez-González, José|||0000-0002-3894-7166
  • Rodríguez, Cristina|||0000-0002-6472-5647
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Activation of Wnt/β-catenin signaling in abdominal aortic aneurysm: A potential therapeutic opportunity?

  • Puertas-Umbert, Lidia
  • álvarez, saray
  • Ballester-Servera, Carme
  • Alonso Nieto, Judith
  • Aguiló, Silvia
  • Orriols, Mar
  • Rodriguez-Sinovas, Antonio
Abdominal aortic aneurysm, Aneurisma aórtico abdominal, Aneurisma aòrtic abdominal, This work was supported by Instituto de Salud Carlos III (ISCIII) (No. PI21/01048, PI20/01649), the European Regional Development Fund (ERDF-FEDER, a way to build Europe), Ministerio de Ciencia e Innovación (No. RTI2018-094727-B-100), AGAUR (No. 2017-SGR-00333, 2017-SGR-1807) and Consejo Superior de Investigaciones Científicas (No. 2021AEP073). L. P. is supported by a PFIS contract (ISCIII), C.B–S by a FPU fellowship and A.R.-S. and M.G. were funded by the Miguel Servet Program.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

NR4A3: A Key Nuclear Receptor in Vascular Biology, Cardiovascular Remodeling, and Beyond

  • Rodríguez Sinovas, Antonio
  • Corrales Insa, Irene
  • Alonso Nieto, Judith
  • Ballester-Servera, Carme
  • Cañes Esteve, Laia
  • Rodriguez, Cristina
  • Martínez-González, José
Aneurisma aórtico abdominal; Aterosclerosis; Remodelación cardiovascular, Aneurisma aòrtic abdominal; Aterosclerosi; Remodelació cardiovascular, Abdominal aortic aneurysm; Atherosclerosis; Cardiovascular remodeling, The mechanisms committed in the activation and response of vascular and inflammatory immune cells play a major role in tissue remodeling in cardiovascular diseases (CVDs) such as atherosclerosis, pulmonary arterial hypertension, and abdominal aortic aneurysm. Cardiovascular remodeling entails interrelated cellular processes (proliferation, survival/apoptosis, inflammation, extracellular matrix (ECM) synthesis/degradation, redox homeostasis, etc.) coordinately regulated by a reduced number of transcription factors. Nuclear receptors of the subfamily 4 group A (NR4A) have recently emerged as key master genes in multiple cellular processes and vital functions of different organs, and have been involved in a variety of high-incidence human pathologies including atherosclerosis and other CVDs. This paper reviews the major findings involving NR4A3 (Neuron-derived Orphan Receptor 1, NOR-1) in the cardiovascular remodeling operating in these diseases., This research was funded by the Spanish Ministerio de Ciencia e Innovación (RTI2018-094727-B-100), Instituto de Salud Carlos III (ISCIII; PI18/0919 and PI20/01649), the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR; 2017-SGR-00333). The study was cofounded by Fondo Europeo de Desarrollo Regional (FEDER), a way to make Europe. C.B.-S. is supported by a FPU fellowship (Ministerio de Ciencia, Innovación y Universidades).